HedgeChatter

IsoRay, Inc. Reports Second Quarter Results 14% of Revenue Attributed to Non Prostate Cases Fueled by New Cancer Facilities

14 Feb

IsoRay, Inc. Reports Second Quarter Results 14% of Revenue Attributed to Non Prostate Cases Fueled by New Cancer Facilities

Bystocknews , Comments Off on IsoRay, Inc. Reports Second Quarter Results 14% of Revenue Attributed to Non Prostate Cases Fueled by New Cancer Facilities

[at noodls] – FOR IMMEDIATE RELEASE ISORAY, INC. REPORTS SECOND QUARTER RESULTS 14% Of Revenue Attributed To Non Prostate Cases Fueled By New Cancer Facilities RICHLAND, Washington (February 14, 2013) – IsoRay, Inc. … more

View todays social media effects on ISR

View the latest stocks trending across Twitter. Click to view dashboard

See who IsoRay is hiring next, click here to view

Share this post

Author

stocknews